Adocia
Adocia SA, a clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company provides BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid prandial insulin lispro; BioChaperone Combo, a combination of act… Read more
Adocia (ADOC) - Total Assets
Latest total assets as of June 2025: €27.24 Million EUR
Based on the latest financial reports, Adocia (ADOC) holds total assets worth €27.24 Million EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Adocia - Total Assets Trend (2008–2024)
This chart illustrates how Adocia’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Adocia - Asset Composition Analysis
Current Asset Composition (December 2024)
Adocia's total assets of €27.24 Million consist of 83.1% current assets and 16.9% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 27.9% |
| Accounts Receivable | €8.73 Million | 32.3% |
| Inventory | €220.00K | 0.8% |
| Property, Plant & Equipment | €3.12 Million | 11.5% |
| Intangible Assets | €4.00K | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2008–2024)
This chart illustrates how Adocia's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Adocia's current assets represent 83.1% of total assets in 2024, an increase from 0.0% in 2008.
- Cash Position: Cash and equivalents constituted 27.9% of total assets in 2024, down from 74.4% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2008.
- Asset Diversification: The largest asset category is accounts receivable at 32.3% of total assets.
Adocia Competitors by Total Assets
Key competitors of Adocia based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Adocia - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Adocia generates 0.34x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Adocia is currently not profitable relative to its asset base.
Adocia - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.14 | 0.92 | 3.75 |
| Quick Ratio | 1.12 | 0.89 | 3.73 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €2.70 Million | € -1.71 Million | € 29.93 Million |
Adocia - Advanced Valuation Insights
This section examines the relationship between Adocia's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.54 |
| Latest Market Cap to Assets Ratio | 3.13 |
| Asset Growth Rate (YoY) | 8.3% |
| Total Assets | €27.02 Million |
| Market Capitalization | $84.57 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Adocia's assets at a significant premium ( 3.13x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: Adocia's assets grew by 8.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Adocia (2008–2024)
The table below shows the annual total assets of Adocia from 2008 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €27.02 Million | +8.27% |
| 2023-12-31 | €24.96 Million | -18.48% |
| 2022-12-31 | €30.61 Million | +1.86% |
| 2021-12-31 | €30.05 Million | -33.46% |
| 2020-12-31 | €45.17 Million | -27.10% |
| 2019-12-31 | €61.95 Million | -11.55% |
| 2018-12-31 | €70.04 Million | +30.29% |
| 2017-12-31 | €53.76 Million | -31.77% |
| 2016-12-31 | €78.80 Million | -10.55% |
| 2015-12-31 | €88.09 Million | +67.66% |
| 2014-12-31 | €52.54 Million | +112.48% |
| 2013-12-31 | €24.73 Million | -32.48% |
| 2012-12-31 | €36.63 Million | +107.68% |
| 2011-12-31 | €17.64 Million | +17.08% |
| 2010-12-31 | €15.06 Million | -4.96% |
| 2009-12-31 | €15.85 Million | +63.32% |
| 2008-12-31 | €9.70 Million | -- |